Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

All Content

  • 1
    News

    Anticoagulant therapy for AFib in patients with end-stage renal disease

    August 23, 2019

    Apixaban may be safer than warfarin for patients who have ESRD and who plan for anticoagulation because of AFib.

  • 1
    News

    FUO, pneumonia often distinguishes influenza from RSV in hospitalized young children

    August 22, 2019

    LJUBLJANA, SLOVENIA – “These findings open new possibilities for antimicrobial stewardship in these groups of virally infected children.” Dr. Cihan Papan.

  • 1
    News

    Treating children with Kawasaki disease and coronary enlargement

    August 22, 2019

    An important new study reveals a treatment protocol that decreases the rate of aneurysm enlargement.

  • 1
    News

    Obtain proper reimbursements with more effective documentation and coding

    August 21, 2019

    Hospitalists should know the factors that influence coding to ensure accuracy and compliance.

  • News

    Dapagliflozin meets primary endpoint in the DAPA-HF trial

    August 21, 2019

    AstraZeneca announces preliminary results in first heart failure trial in an SGLT2 inhibitor.

  • 1
    Opinion

    Am I still a hospitalist?

    August 20, 2019

    Hospital medicine and health care delivery systems should drive change in a coordinated, collaborative partnership.

  • News

    New biomarker model outmatches conventional risk factors for predicting mortality

    August 20, 2019

    Although the majority of these biomarkers have been associated with mortality before, this is the first study that shows their independent effect when combined into one model.

  • 1
    News

    FDA approves Xenleta for community-acquired bacterial pneumonia treatment

    August 20, 2019

    The approval was based on results from two trials with a total of 1,289 patients.

  • 1
    News

    Short-term parenteral antibiotics effective for bacteremic UTI in young infants

    August 20, 2019

    No significant differences in urinary tract infection recurrence or hospital reutilization between short- and long-term parenteral antibiotic groups.

  • News

    Post-TAVR anticoagulation alone fails to cut stroke risk in AFib

    August 19, 2019

    By contrast, antiplatelet therapy linked to reduced risk of stroke, whether or not oral anticoagulation was used in this PARTNER II substudy.

Previous1 … 214 215 216 217 218 … 861Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences